State of the Art: No-Reflow Phenomenon
- PMID: 33036718
- DOI: 10.1016/j.ccl.2020.07.001
State of the Art: No-Reflow Phenomenon
Abstract
Primary percutaneous coronary intervention is the preferred reperfusion strategy for the management of acute ST-segment elevation myocardial infarction. No reflow is characterized by the inadequate myocardial perfusion of a given segment without angiographic evidence of persistent mechanical obstruction of epicardial vessels. Both pharmacologic and device-based strategies have been tested to resolve coronary no reflow. This article provides an updated overview of the no-reflow phenomenon, discussing clinical evidence and ongoing investigations of existing and novel therapeutic strategies to counteract it.
Keywords: Microvascular obstruction; No-reflow; Primary PCI.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have no commercial or financial conflicts of interest; no funding has been received for this article.
Similar articles
-
Impact of clopidogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention.Coron Artery Dis. 2012 Dec;23(8):523-7. doi: 10.1097/MCA.0b013e3283596c29. Coron Artery Dis. 2012. PMID: 23011413
-
The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.Coron Artery Dis. 2015 May;26(3):245-53. doi: 10.1097/MCA.0000000000000197. Coron Artery Dis. 2015. PMID: 25503419
-
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27. Cardiol J. 2016. PMID: 26503078
-
[No-reflow: update on diagnosis, pathophysiology and therapeutic strategies].G Ital Cardiol (Rome). 2020 Jun;21(6 Suppl 1):4S-14S. doi: 10.1714/3373.33487. G Ital Cardiol (Rome). 2020. PMID: 32469339 Review. Italian.
-
The challenges and impact of microvascular injury in ST-elevation myocardial infarction.Expert Rev Cardiovasc Ther. 2016;14(4):431-43. doi: 10.1586/14779072.2016.1135055. Epub 2016 Jan 22. Expert Rev Cardiovasc Ther. 2016. PMID: 26794717 Review.
Cited by
-
Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach.Diagnostics (Basel). 2023 Feb 13;13(4):709. doi: 10.3390/diagnostics13040709. Diagnostics (Basel). 2023. PMID: 36832197 Free PMC article.
-
Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease.Int J Mol Sci. 2024 May 28;25(11):5852. doi: 10.3390/ijms25115852. Int J Mol Sci. 2024. PMID: 38892037 Free PMC article. Review.
-
Coronary Endothelium No-Reflow Injury Is Associated with ROS-Modified Mitochondrial Fission through the JNK-Drp1 Signaling Pathway.Oxid Med Cell Longev. 2021 Jan 30;2021:6699516. doi: 10.1155/2021/6699516. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33613824 Free PMC article.
-
Quantifying Microvascular Structure in Healthy and Infarcted Rat Hearts Using Optical Coherence Tomography Angiography.IEEE Trans Med Imaging. 2024 Aug;43(8):2878-2887. doi: 10.1109/TMI.2024.3381934. Epub 2024 Aug 1. IEEE Trans Med Imaging. 2024. PMID: 38568757 Free PMC article.
-
How an Aggressive Treatment of No-reflow Phenomenon in Primary Percutaneous Coronary Intervention with High Thrombus Burden can Achieve a Grade III TIMI-flow: A Case Report.Int J Angiol. 2023 Apr 10;34(3):233-237. doi: 10.1055/s-0043-1764475. eCollection 2025 Sep. Int J Angiol. 2023. PMID: 40771288 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous